Heterogeneity of CD5 membrane expression on b-chronic lymphocytic leukemia cells

Neil Elliot Kay, Loann Peterson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The CD5 antigen has been used to characterize the typical B-chronic lymphocytic leukemia B cell. CD5 antigen while found on mature T cells is also frequently found on malignant clonal B cells in B-CLL. We have sequentially evaluated the presence of CD5 antigen on a group of B-CLL cells using flow cytometry. Purified peripheral blood B cells from B-CLL patients were studied for the presence of both CD19 and CD5. This approach insured that the presence of CD5 antigen was only assessed on CD19 positive B cells. Our data suggests that there is considerable heterogeneity for presentation of CD5 antigen in clonal B cells in this disease. We define 3 B cell groups based on the presentation of CD5; low CD5, intermediate CD5 and high CD5 antigen positive B cells. In addition sequential analysis over several months of study indicates that the CD5 antigen is consistently present on these clonal B cells. Low CD5 B cells appear to have an excess of kappa phenotype. In conclusion CD5 antigen may be considerably more heterogeneous on clonal CLL B cells than previously thought. This variable presentation of CD5 antigen on CLL B cell clones needs to be considered in the assessment and characterization of B-CLL.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalLeukemia and Lymphoma
Volume5
Issue number1
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

CD5 Antigens
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Membranes
B-Cell Leukemia
Blood Cells
Flow Cytometry
Clone Cells

Keywords

  • CD5 CLL cells

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Heterogeneity of CD5 membrane expression on b-chronic lymphocytic leukemia cells. / Kay, Neil Elliot; Peterson, Loann.

In: Leukemia and Lymphoma, Vol. 5, No. 1, 1991, p. 49-55.

Research output: Contribution to journalArticle

@article{8478ef4e82d44c1e8d1791a06ce91e68,
title = "Heterogeneity of CD5 membrane expression on b-chronic lymphocytic leukemia cells",
abstract = "The CD5 antigen has been used to characterize the typical B-chronic lymphocytic leukemia B cell. CD5 antigen while found on mature T cells is also frequently found on malignant clonal B cells in B-CLL. We have sequentially evaluated the presence of CD5 antigen on a group of B-CLL cells using flow cytometry. Purified peripheral blood B cells from B-CLL patients were studied for the presence of both CD19 and CD5. This approach insured that the presence of CD5 antigen was only assessed on CD19 positive B cells. Our data suggests that there is considerable heterogeneity for presentation of CD5 antigen in clonal B cells in this disease. We define 3 B cell groups based on the presentation of CD5; low CD5, intermediate CD5 and high CD5 antigen positive B cells. In addition sequential analysis over several months of study indicates that the CD5 antigen is consistently present on these clonal B cells. Low CD5 B cells appear to have an excess of kappa phenotype. In conclusion CD5 antigen may be considerably more heterogeneous on clonal CLL B cells than previously thought. This variable presentation of CD5 antigen on CLL B cell clones needs to be considered in the assessment and characterization of B-CLL.",
keywords = "CD5 CLL cells",
author = "Kay, {Neil Elliot} and Loann Peterson",
year = "1991",
doi = "10.3109/10428199109068104",
language = "English (US)",
volume = "5",
pages = "49--55",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Heterogeneity of CD5 membrane expression on b-chronic lymphocytic leukemia cells

AU - Kay, Neil Elliot

AU - Peterson, Loann

PY - 1991

Y1 - 1991

N2 - The CD5 antigen has been used to characterize the typical B-chronic lymphocytic leukemia B cell. CD5 antigen while found on mature T cells is also frequently found on malignant clonal B cells in B-CLL. We have sequentially evaluated the presence of CD5 antigen on a group of B-CLL cells using flow cytometry. Purified peripheral blood B cells from B-CLL patients were studied for the presence of both CD19 and CD5. This approach insured that the presence of CD5 antigen was only assessed on CD19 positive B cells. Our data suggests that there is considerable heterogeneity for presentation of CD5 antigen in clonal B cells in this disease. We define 3 B cell groups based on the presentation of CD5; low CD5, intermediate CD5 and high CD5 antigen positive B cells. In addition sequential analysis over several months of study indicates that the CD5 antigen is consistently present on these clonal B cells. Low CD5 B cells appear to have an excess of kappa phenotype. In conclusion CD5 antigen may be considerably more heterogeneous on clonal CLL B cells than previously thought. This variable presentation of CD5 antigen on CLL B cell clones needs to be considered in the assessment and characterization of B-CLL.

AB - The CD5 antigen has been used to characterize the typical B-chronic lymphocytic leukemia B cell. CD5 antigen while found on mature T cells is also frequently found on malignant clonal B cells in B-CLL. We have sequentially evaluated the presence of CD5 antigen on a group of B-CLL cells using flow cytometry. Purified peripheral blood B cells from B-CLL patients were studied for the presence of both CD19 and CD5. This approach insured that the presence of CD5 antigen was only assessed on CD19 positive B cells. Our data suggests that there is considerable heterogeneity for presentation of CD5 antigen in clonal B cells in this disease. We define 3 B cell groups based on the presentation of CD5; low CD5, intermediate CD5 and high CD5 antigen positive B cells. In addition sequential analysis over several months of study indicates that the CD5 antigen is consistently present on these clonal B cells. Low CD5 B cells appear to have an excess of kappa phenotype. In conclusion CD5 antigen may be considerably more heterogeneous on clonal CLL B cells than previously thought. This variable presentation of CD5 antigen on CLL B cell clones needs to be considered in the assessment and characterization of B-CLL.

KW - CD5 CLL cells

UR - http://www.scopus.com/inward/record.url?scp=0025880249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025880249&partnerID=8YFLogxK

U2 - 10.3109/10428199109068104

DO - 10.3109/10428199109068104

M3 - Article

VL - 5

SP - 49

EP - 55

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1

ER -